Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Principal Healthcare Innovators Index (BTEC)

Principal Healthcare Innovators Index (BTEC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
Trade BTEC with:
  • Price/Earnings ttm 14.52
  • Annual Dividend & Yield 0.22
  • Most Recent Dividend 0.215
  • Management Fee 0.42%
  • Sectors:

    ETFs - Large Cap

Price Performance

See More
Period Period Low Period High Performance
1-Month
57.52 +10.71%
on 01/04/21
64.86 -1.82%
on 01/15/21
+3.56 (+5.92%)
since 12/15/20
3-Month
47.87 +33.03%
on 11/02/20
64.86 -1.82%
on 01/15/21
+12.59 (+24.64%)
since 10/15/20
52-Week
25.34 +151.30%
on 03/18/20
64.86 -1.82%
on 01/15/21
+24.32 (+61.80%)
since 01/15/20

Most Recent Stories

More News
A Guide to Biotech ETF Investing Amid the Coronavirus Crisis

The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.

PFE : 36.70 (-0.14%)
MRNA : 129.65 (-0.05%)
LLY : 190.77 (+2.19%)
IBB : 161.71 (-0.10%)
CNCR : 34.65 (-1.00%)
XBI : 151.73 (-1.11%)
BBH : 180.97 (+0.53%)
FBT : 176.29 (+0.05%)
SBIO : 56.23 (-1.00%)
PBE : 76.14 (-0.12%)
BTEC : 63.68 (-0.75%)
ARKG : 107.96 (-1.23%)
BNTX : 101.59 (-4.02%)
Top-Performing Biotech ETFs Amid the COVID-19 Crisis

The coronavirus pandemic triggered a race to introduce vaccine and treatment, thereby opening up new investing opportunities in the biotech sector in 2020.

XBI : 151.73 (-1.11%)
BTEC : 63.68 (-0.75%)
ARKG : 107.96 (-1.23%)
GNOM : 26.31 (-0.04%)
IDNA : 51.32 (-0.81%)
Moderna ETFs to Shine on Vaccine News as Outbreak Worsens

Positive coronavirus vaccine progress from Moderna (MRNA) has hogged investors' attention.

IBB : 161.71 (-0.10%)
XBI : 151.73 (-1.11%)
BBH : 180.97 (+0.53%)
BTEC : 63.68 (-0.75%)
IDNA : 51.32 (-0.81%)
GERM : 35.82 (+0.67%)
Moderna Expects COVID-19 Vaccine Data in November: ETFs to Gain

Positive comment on coronavirus vaccine progress from Moderna's (MRNA) CEO during The Wall Street Journal's annual Tech Live conference has gained investors attention and raised vaccine optimism.

IBB : 161.71 (-0.10%)
XBI : 151.73 (-1.11%)
BBH : 180.97 (+0.53%)
BTEC : 63.68 (-0.75%)
IDNA : 51.32 (-0.81%)
GERM : 35.82 (+0.67%)
Healthcare ETFs, Stocks That Gained Double Digits Last Week

The healthcare sector defied last week's market rout buoyed by the progress in the development of a coronavirus vaccine or treatment, and merger and acquisition news.

AZN : 51.34 (+0.10%)
PFE : 36.70 (-0.14%)
GILD : 63.33 (+1.49%)
IMMU : 87.86 (+0.05%)
MRNS : 12.60 (-1.02%)
PTH : 176.38 (-1.25%)
WVE : 9.13 (+1.78%)
BBC : 53.82 (-0.48%)
BTEC : 63.68 (-0.75%)
NVUS : 14.60 (-5.19%)
SAVA : 10.57 (+0.86%)
IDNA : 51.32 (-0.81%)
IBBJ : 37.30 (-1.06%)
4 Best-Performing Sector ETFs of Last Week

The S&P 500, the Dow Jones and the Nasdaq Composite have lost about 0.6%, 0.03% and 0.6%, respectively, past week.

AZN : 51.34 (+0.10%)
CZR : 80.00 (+2.35%)
LIT : 68.29 (-1.04%)
BTEC : 63.68 (-0.75%)
DKNG : 53.70 (-2.22%)
BETZ : 28.67 (-1.82%)
IBBJ : 37.30 (-1.06%)
Moderna ETFs to Gain on New Positive COVID-19 Vaccine Data

Per the latest data from an early stage clinical trial, Moderna's experimental coronavirus vaccine is successfully producing neutralizing antibodies and T-cells in older adults.

MRNA : 129.65 (-0.05%)
IBB : 161.71 (-0.10%)
CNCR : 34.65 (-1.00%)
XBI : 151.73 (-1.11%)
BBH : 180.97 (+0.53%)
BTEC : 63.68 (-0.75%)
IDNA : 51.32 (-0.81%)
GERM : 35.82 (+0.67%)
Why Small-Cap Biotech ETFs Are Good Long-Term Bets

Small-cap biotech ETFs may prove to be winning bets with or without coronavirus.

BBC : 53.82 (-0.48%)
BTEC : 63.68 (-0.75%)
IDNA : 51.32 (-0.81%)
IBBJ : 37.30 (-1.06%)
Moderna ETFs to Shine on U.S. Contracts for Coronavirus Vaccine

Moderna has inked a $1.5-billion coronavirus vaccine supply agreement with the U.S. government.

MRNA : 129.65 (-0.05%)
IBB : 161.71 (-0.10%)
CNCR : 34.65 (-1.00%)
XBI : 151.73 (-1.11%)
BBH : 180.97 (+0.53%)
BTEC : 63.68 (-0.75%)
IDNA : 51.32 (-0.81%)
GERM : 35.82 (+0.67%)
Stocks & ETFs Beneficiaries of Coronavirus Vaccine Ramp-Up

Efforts in formulating a coronavirus vaccine are heating up. These stocks and ETFs look to be the largest beneficiaries.

AZN : 51.34 (+0.10%)
MRNA : 129.65 (-0.05%)
GSK : 38.47 (+0.81%)
NVAX : 127.43 (-1.96%)
CNCR : 34.65 (-1.00%)
INO : 9.66 (+3.09%)
PTH : 176.38 (-1.25%)
BBC : 53.82 (-0.48%)
BTEC : 63.68 (-0.75%)
ARKG : 107.96 (-1.23%)
IDN : 12.28 (+2.08%)
VXRT : 7.18 (-2.18%)
GNOM : 26.31 (-0.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Fund Summary

The Principal Healthcare Innovators Index ETF seeks to provide investment results that closely correspond, before expenses, to the performance of the NASDAQ U.S. Healthcare Innovators Index. The ETF employs a passive investment approach designed to track the performance of the Index.

See More

Top 10 Holdings

Name % Holdings
60770K107 4.28%
98956P102 2.78%
30063P105 2.69%
02043Q107 2.33%
87918A105 2.23%
G46188101 2.10%
81181C104 2.09%
40131M109 1.90%
09061G101 1.80%
H17182108 1.79%

See More

Key Turning Points

3rd Resistance Point 66.29
2nd Resistance Point 65.57
1st Resistance Point 64.63
Last Price 63.68
1st Support Level 62.97
2nd Support Level 62.25
3rd Support Level 61.31

See More

52-Week High 64.86
Last Price 63.68
Fibonacci 61.8% 49.76
Fibonacci 50% 45.10
Fibonacci 38.2% 40.44
52-Week Low 25.34

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar